Side-by-side comparison of AI visibility scores, market position, and capabilities
New York specialty ingredients (NYSE: IFF) at $11.48B 2024 net sales, EBITDA +16%; flavors/fragrances + N&B health/biosciences ($26B 2021 acquisition), 2025 guidance 1-4% growth competing with Givaudan and dsm-firmenich.
International Flavors & Fragrances Inc. (IFF) is a New York City, New York-based global specialty ingredients company — publicly traded on the New York Stock Exchange (NYSE: IFF) as an S&P 500 Materials component — creating and manufacturing flavors, fragrances, enzymes, probiotics, food ingredients, cosmetic actives, and pharmaceutical excipients for consumer goods companies, food manufacturers, beverage companies, and pharmaceutical firms through approximately 20,000 employees in 110 countries. In fiscal year 2024, IFF reported net sales of $11.48 billion and adjusted operating EBITDA growth of 16% to $2.21 billion, demonstrating improved profitability following the challenging integration of the DuPont Nutrition & Biosciences business (acquired 2021 for ~$26 billion in the largest transaction in IFF's history). For 2025, IFF guided 1-4% comparable currency-neutral sales growth, with continued margin improvement as the integration synergies are realized. CEO Jon Erik Fyrwald leads the company through its integration and portfolio optimization phase. IFF operates across four segments: Nourish (flavors, functional ingredients, proteins, food and beverage innovation), Scent (fine fragrances, consumer fragrances, cosmetic actives), Health & Biosciences (enzymes, microbiome, probiotics, animal nutrition), and Pharma Solutions (pharmaceutical excipients and delivery systems) — serving every major category of consumer products from food and beverages to personal care, household products, and medicine.
Falls Church stealth defense systems (NYSE: NOC) ~$41B revenue; B-21 Raider stealth bomber (operational 2024), Sentinel ICBM, $1.4B IBCS air defense contracts for US Army and Poland competing with Lockheed Martin.
Northrop Grumman Corporation is a Falls Church, Virginia-based global aerospace and defense technology company — publicly traded on the New York Stock Exchange (NYSE: NOC) as an S&P 500 Industrials component — designing, developing, producing, and maintaining advanced defense systems including stealth combat aircraft, space systems, ground-based strategic nuclear weapons, battle management systems, and unmanned systems through approximately 95,000 employees worldwide. In fiscal year 2024, Northrop Grumman reported revenue of approximately $41 billion, with defense spending tailwinds from NATO alliance expansion, Indo-Pacific military modernization, and US Air Force strategic deterrence modernization. Northrop Grumman secured $1.4 billion in contracts to advance the Integrated Battle Command System (IBCS) — a next-generation air and missile defense battle management system for the US Army and Poland, connecting disparate sensors (radar, sonar, space-based sensors) and effectors (Patriot batteries, short-range air defense missiles) through a unified software-defined kill chain. CEO Kathy Warden — the first female CEO of a major US defense contractor — leads Northrop's strategy of focusing on the highest-technology defense programs where integration complexity creates durable sole-source competitive positions. The B-21 Raider stealth strategic bomber (the first new US strategic bomber in 35 years, beginning operational deliveries in 2024) is Northrop's defining program — a next-generation nuclear-capable stealth aircraft intended to replace the B-2 Spirit and eventually the B-1 Lancer through the late 2030s.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.